Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of dextrose and a local anesthetic (such as lidocaine or bupivacaine) is used in various clinical settings, most commonly for regional anesthesia (including spinal, epidural, and peripheral nerve blocks), pain management procedures, and regenerative injection therapies like prolotherapy. The local anesthetic component acts by stabilizing neuronal membranes and inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, resulting in loss of sensation or pain relief. Dextrose serves primarily as a vehicle to adjust solution baricity (density relative to cerebrospinal fluid) for spinal/epidural use—making the solution hyperbaric—or as an active agent in regenerative therapies where it may promote tissue repair or modulate pain pathways. This combination is not a single branded product but rather a formulation used clinically with different local anesthetics depending on indication[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose + local anesthetic.